FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4377015811> ?p ?o ?g. }

• W4377015811 endingPage "S528" @default.
• W4377015811 startingPage "S527" @default.
• W4377015811 abstract "Paroxysmal Supraventricular Tachycardia (PSVT) treatment requires medically supervised intervention. This is derived from the lack of effective and safe self-administrated treatment for PSVT. Etripamil is a novel short-acting calcium channel blocker with a rapid intranasal spray and shows promising potential for the unsupervised treatment of PSVT, especially in the dosage of 70 mg. We aim to evaluate the efficacy and safety of Etripamil for the acute conversion of PSVT. We conducted a systematic review and meta-analysis synthesizing randomized controlled trials (RCTs), which were retrieved by systematically searching: PubMed, EMBASE, Web of Science, SCOPUS, and Cochrane through December 1st, 2022. RevMan version 5.4 software was used to pool dichotomous outcomes using risk ratio (RR) presented with the corresponding confidence interval (CI) while using the fixed-effects model. Three RCTs with a total of 496 patients (296 in the etripamil group and 200 in the placebo group) were included in our analysis. Etripamil was effective for PSVT conversion at 15 minutes (RR: 1.84 with 95% CI [1.37, 2.48]), 30 minutes (RR: 1.86 with 95% CI [1.42, 2.44]), and at 60 minutes after the drug administration (RR: 1.25 with 95% CI [1.05, 1.50]); decreasing medical intervention seeking (RR: 0.58 with 95% CI [0.37, 0.90]); and decreasing emergency (ER) visits (RR: 0.61 with 95% CI [0.38, 0.97]). However, there was no difference at 300 minutes (RR: 1.10 with 95% CI [0.97, 1.25]). Also, Etripamil was associated with higher rates of the incidence of any adverse events (AEs) (RR: 3.17 with 95% CI [2.15, 4.69]), nasal discomfort (RR: 3.82 with 95% CI [2.01, 7.24]), nasal congestion (RR: 5.89 with 95% CI [1.93, 17.97]), epistaxis (RR: 4.74 with 95% CI [1.21, 18.50]), and rhinorrhea (RR: 3.53 with 95% CI [1.22, 10.26]) with no difference regarding any serious adverse events (SAEs) incidence (RR: 0.30 with 95% CI [0.01, 7.21]). Etripamil was effective in inducing PSVT termination for up to 60 minutes and reduced medical treatment seeking and ER visits. Also, Etripamil was associated with higher rates of AEs, including epistaxis, nasal congestion, and rhinorrhea; however, it was not associated with SAEs. Therefore, Etripamil constitutes a promising strategy for PSVT self-termination without medical supervision; however, further RCTs are required before endorsement in clinical practice." @default.
• W4377015811 created "2023-05-19" @default.
• W4377015811 creator A5011918442 @default.
• W4377015811 creator A5026288679 @default.
• W4377015811 creator A5032105816 @default.
• W4377015811 creator A5061761706 @default.
• W4377015811 creator A5076355656 @default.
• W4377015811 creator A5091971781 @default.
• W4377015811 date "2023-05-01" @default.
• W4377015811 modified "2023-09-30" @default.
• W4377015811 title "PO-04-108 THE EFFICACY AND SAFETY OF ETRIPAMIL NASAL SPRAY FOR THE TREATMENT OF ACUTE PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS" @default.
• W4377015811 doi "https://doi.org/10.1016/j.hrthm.2023.03.1131" @default.
• W4377015811 hasPublicationYear "2023" @default.
• W4377015811 type Work @default.
• W4377015811 citedByCount "0" @default.
• W4377015811 crossrefType "journal-article" @default.
• W4377015811 hasAuthorship W4377015811A5011918442 @default.
• W4377015811 hasAuthorship W4377015811A5026288679 @default.
• W4377015811 hasAuthorship W4377015811A5032105816 @default.
• W4377015811 hasAuthorship W4377015811A5061761706 @default.
• W4377015811 hasAuthorship W4377015811A5076355656 @default.
• W4377015811 hasAuthorship W4377015811A5091971781 @default.
• W4377015811 hasBestOaLocation W43770158111 @default.
• W4377015811 hasConcept C126322002 @default.
• W4377015811 hasConcept C142724271 @default.
• W4377015811 hasConcept C168563851 @default.
• W4377015811 hasConcept C204787440 @default.
• W4377015811 hasConcept C27081682 @default.
• W4377015811 hasConcept C2776478404 @default.
• W4377015811 hasConcept C2777204175 @default.
• W4377015811 hasConcept C2780283014 @default.
• W4377015811 hasConcept C42219234 @default.
• W4377015811 hasConcept C44249647 @default.
• W4377015811 hasConcept C71924100 @default.
• W4377015811 hasConcept C82789193 @default.
• W4377015811 hasConcept C95190672 @default.
• W4377015811 hasConceptScore W4377015811C126322002 @default.
• W4377015811 hasConceptScore W4377015811C142724271 @default.
• W4377015811 hasConceptScore W4377015811C168563851 @default.
• W4377015811 hasConceptScore W4377015811C204787440 @default.
• W4377015811 hasConceptScore W4377015811C27081682 @default.
• W4377015811 hasConceptScore W4377015811C2776478404 @default.
• W4377015811 hasConceptScore W4377015811C2777204175 @default.
• W4377015811 hasConceptScore W4377015811C2780283014 @default.
• W4377015811 hasConceptScore W4377015811C42219234 @default.
• W4377015811 hasConceptScore W4377015811C44249647 @default.
• W4377015811 hasConceptScore W4377015811C71924100 @default.
• W4377015811 hasConceptScore W4377015811C82789193 @default.
• W4377015811 hasConceptScore W4377015811C95190672 @default.
• W4377015811 hasIssue "5" @default.
• W4377015811 hasLocation W43770158111 @default.
• W4377015811 hasOpenAccess W4377015811 @default.
• W4377015811 hasPrimaryLocation W43770158111 @default.
• W4377015811 hasRelatedWork W2114346778 @default.
• W4377015811 hasRelatedWork W2217553306 @default.
• W4377015811 hasRelatedWork W2374685850 @default.
• W4377015811 hasRelatedWork W2381982637 @default.
• W4377015811 hasRelatedWork W2531052508 @default.
• W4377015811 hasRelatedWork W2626084264 @default.
• W4377015811 hasRelatedWork W2914141471 @default.
• W4377015811 hasRelatedWork W3013041320 @default.
• W4377015811 hasRelatedWork W3030276453 @default.
• W4377015811 hasRelatedWork W4212933565 @default.
• W4377015811 hasVolume "20" @default.
• W4377015811 isParatext "false" @default.
• W4377015811 isRetracted "false" @default.
• W4377015811 workType "article" @default.